Medical Record Interoperability

Helped a leader in EMR indexing develop growth options in adjacent markets as new interoperability rules reshaped the hospital segment.

Strategic AI Assessment: Positioning a Healthcare Data Leader

Helped a dominant clinical decision support and ePrescribing company assess AI threats and opportunities and realign strategy for sustainable growth.

Medical Imaging: From Market Assessment to FDA Clearance

Conducted U.S. market assessment and reimbursement strategy for an imaging innovator pre-FDA clearance, helping position the company for regulatory approval and market entry.

AI-Powered Medication Safety: Turning Smarter Alerts Into Safer Care

Developed a business case and integration strategy for an AI-driven medication alert platform navigating complex hospital and payer incentives.

Interoperability as Opportunity: Repositioning for Accelerated Growth

New interoperability rules threatened demand for the client's core hospital indexing product. HBG gauged regulatory risk and identified growth paths beyond hospitals.

CCM/RPM Diligence: Testing Investment Thesis Under Regulatory Uncertainty

Helped an investor assess reimbursement and policy risk for a chronic care management and remote monitoring acquisition before bidding.

Remote Patient Monitoring

Helped an RPM company accelerate growth by adding a consumer pay offering — including consumer research, partnership identification, and go-to-market planning.

Decentralized Clinical Trials

Helped a mobile vision center company decide whether to invest in building a long-term clinical trials business after pivoting during the pandemic.

Digital Health for Leading Retailer

Supported a major retailer's innovation group in developing and prioritizing digital health offerings to complement its in-store clinic strategy.